144.50
-0.95
(-0.65%)
As of 8:05:02 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 11 | 11 |
| Avg. Estimate | 4.93B | 5.5B | 21.5B | 22.56B |
| Low Estimate | 4.85B | 5.45B | 20B | 20.89B |
| High Estimate | 5B | 5.6B | 22.11B | 23.85B |
| Year Ago Sales | 4.87B | 5.42B | 21B | 21.5B |
| Sales Growth (year/est) | 1.24% | 1.43% | 2.37% | 4.93% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CDW.F | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 2/6/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 2/6/2025 |
| Maintains | UBS: Buy to Buy | 1/7/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 12/16/2024 |
| Initiated | Redburn Atlantic: Buy | 11/15/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 10/31/2024 |